|
1
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Karimi P, Islami F, Anandasabapathy S,
Freedman ND and Kamangar F: Gastric cancer: Descriptive
epidemiology, risk factors, screening, and prevention. Cancer
Epidemiol Biomarkers Prev. 23:700–713. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Papenfuss WA, Kukar M, Oxenberg J, Attwood
K, Nurkin S, Malhotra U and Wilkinson NW: Morbidity and mortality
associated with gastrectomy for gastric cancer. Ann Surg Oncol.
21:30082014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wöhrer SS, Raderer M and Hejna M:
Palliative chemotherapy for advanced gastric cancer. Ann Oncol.
15:1585–1595. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chen L, Yang H, Yi Z, Jiang L, Li Y, Han
Q, Yang Y, Zhang Q, Yang Z, Kuang Y, et al: LncRNA GAS5 regulates
redox balance and dysregulates the cell cycle and apoptosis in
malignant melanoma cells. J Cancer Res Clin Oncol. 2018.
|
|
6
|
Zhang LL, Hu D and Zou LH: Low expression
of lncRNA MEG3 promotes the progression of oral squamous cell
carcinoma by targeting miR-21. Eur Rev Med Pharmacol Sci.
22:8315–8323. 2018.PubMed/NCBI
|
|
7
|
Tu X, Hong D, Jiang Y, Lou Z, Wang K,
Jiang Y and Jin L: FH535 inhibits proliferation and migration of
colorectal cancer cells by regulating CyclinA2 and
Claudin1 gene expression. Gene. 690:48–56. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tsai LH, Delalle I, Caviness VS Jr, Chae T
and Harlow E: p35 is a neural-specific regulatory subunit of
cyclin-dependent kinase 5. Nature. 371:419–423. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wu J, Jiang H, Luo S, Zhang M, Zhang Y,
Sun F, Huang S and Li H: Caspase-mediated cleavage of C53/LZAP
protein causes abnormal microtubule bundling and rupture of the
nuclear envelope. Cell Res. 23:691–704. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang X, Ching YP, Lam WH, Qi Z, Zhang M
and Wang JH: Identification of a common protein association region
in the neuronal Cdk5 activator. J Biol Chem. 275:31763–31769. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lew J, Beaudette K, Litwin CM and Wang JH:
Purification and characterization of a novel proline-directed
protein kinase from bovine brain. J Biol Chem. 267:13383–13390.
1992.PubMed/NCBI
|
|
12
|
Stav D, Bar I and Sandbank J: Usefulness
of CDK5RAP3, CCNB2, and RAGE genes for the diagnosis of lung
adenocarcinoma. Int J Biol Markers. 22:108–113. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Mak WY, Lai WL, Zhou Y, Li M, Ng OL and
Ching YP: CDK5RAP3 is a novel repressor of p14ARF
in hepatocellular carcinoma cells. PLoS One. 7:e422102012.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhao J, Pan K, Li J, Chen YB, Chen JG, Lv
L, Wang DD, Pan QZ, Chen MS and Xia JC: Identification of LZAP as a
new candidate tumor suppressor in hepatocellular carcinoma. PLoS
One. 6:e266082011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Amin MB, Edge S, Greene F, Byrd DR,
Brookland RK, Washington MK, Gershenwald JE, Compton CC, Hess KR,
Sullivan DC, et al: AJCC Cancer Staging Manual. (8th). (New York,
Springer). 2016.
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔCT method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mak GW, Chan MM, Leong VY, Lee JM, Yau TO,
Ng IO and Ching YP: Overexpression of a novel activator of PAK4,
the CDK5 kinase-associated protein CDK5RAP3, promotes
hepatocellular carcinoma metastasis. Cancer Res. 71:2949–2958.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Marlowe JL and Puga A: Aryl hydrocarbon
receptor, cell cycle regulation, toxicity, and tumorigenesis. J
Cell Biochem. 96:1174–1184. 2010. View Article : Google Scholar
|
|
19
|
Ching YP, Pang AS, Lam WH, Qi RZ and Wang
JH: Identification of a neuronal Cdk5 activator-binding protein as
Cdk5 inhibitor. J Biol Chem. 277:15237–15240. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang J, An H, Mayo MW, Baldwin AS and
Yarbrough WG: LZAP, a putative tumor suppressor, selectively
inhibits NF-kappaB. Cancer Cell. 12:239–251. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen J, Liu B, Liu Y, Han Y, Yu H, Zhang
Y, Lu L, Zhen Y and Hui R: A novel gene IC53 stimulates ECV304 cell
proliferation and is upregulated in failing heart. Biochem Biophys
Res Commun. 294:161–166. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen J, Shi Y, Li Z, Yu H, Han Y, Wang X,
Sun K, Yang T, Lou K, Song Y, et al: A functional variant of IC53
correlates with the late onset of colorectal cancer. Mol Med.
17:607–618. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Xie YH, He XH, Tang YT, Li JJ, Pan ZM, Qin
WX, Wan DF and Gu JR: Cloning and characterization of human IC53-2,
a novel CDK5 activator binding protein. Cell Res. 13:83–91. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Motokura T, Bloom T, Kim HG, Jüppner H,
Ruderman JV, Kronenberg HM and Arnold A: A novel cyclin encoded by
a bcl1-linked candidate oncogene. Nature. 350:512–515. 1991.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhou JX, Niehans GA, Shar A, Rubins JB,
Frizelle SP and Kratzke RA: Mechanisms of G1 checkpoint loss in
resected early stage non-small cell lung cancer. Lung Cancer.
32:27–38. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kamb A, Gruis NA, Weaverfeldhaus J, Liu Q,
Harshman K, Tavtigian SV, Stockert E, Day RS III, Johnson BE and
Skolnick MH: A cell cycle regulator potentially involved in genesis
of many tumor types. Science. 264:436–440. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Moghaddam SJ, Haghighi EN, Samiee S,
Shahid N, Keramati AR, Dadgar S and Zali MR: Immunohistochemical
analysis of p53, cyclinD1, RB1, c-fos and N-ras gene expression in
hepatocellular carcinoma in Iran. World J Gastroenterol.
13:588–593. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liu L, Zhang H, Shi L, Zhang W, Yuan J,
Chen X, Liu J, Zhang Y and Wang Z: Inhibition of Rac1 activity
induces G1/S phase arrest through the GSK3/cyclin D1 pathway in
human cancer cells. Oncol Rep. 32:1395–1400. 2014. View Article : Google Scholar : PubMed/NCBI
|
